Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01517802
Title A Study That Provides Long-term Safety Follow-up and Examines Long-term Exposure to Abiraterone Acetate
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | SWE | GBR | ESP | DEU | BEL | AUS

Facility Status City State Zip Country Details
Aurora Colorado United States Details
Marrero Louisiana United States Details
Boston Massachusetts United States Details
Omaha Nebraska United States Details
East Setauket New York United States Details
New York New York United States Details
Myrtle Beach South Carolina United States Details
Chattanooga Tennessee United States Details
Dallas Texas United States Details
Houston Texas United States Details
Kogarah Australia Details
Kurralta Park Australia Details
South Brisbane Australia Details
Subiaco Australia Details
Antwerpen Belgium Details
Hamburg Germany Details
Barcelona Spain Details
Uppsala Sweden Details
Newcastle Upon Tyne United Kingdom Details
Northwood United Kingdom Details
Sutton United Kingdom Details
Whitchurch United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field